Members of the Infectious Disease Working Party and Near Patient Testing Working Party may be interested in this McKinsey-produced report which examines how European health systems used in vitro diagnostic testing in new ways to tackle COVID-19 and how leaders can apply this monumental mobilisation to best use diagnostics as a means of transforming health outcomes in the future.
This includes outlining five priorities which can help heath systems to sustain the progress developed through the pandemic and continue the momentum into the future.
We will produce an analysis of the piece for general reading in next week’s newsletter.
You can read the report here.
